本康生物制药(深圳)有限公司
民营公司 50-150人 制药/生物工程
民营公司 50-150人 制药/生物工程
公司简介 本康生物制药(深圳)有限公司(BenHealth)是专业从事生物制药和细胞治疗创新工具与技术解决方案的公司。依托公司在蛋白质工程研究的多年积累,储备了大量有望改造和提升细胞免疫治疗技术的工具,涵盖创新型双特异性抗体药物的开发、细胞培养方案及细胞表型控制、基于磁珠的细胞分离技术以及细胞检测等诸多方面。此外,针对AMT/AMNK细胞靶向修饰、靶向CTL的DC技术及TIL研究等领域,本康生物也已建立起一系列先进研发平台。本康生物将不断地创新,提高输出产品与技术的品质,让免疫治疗变得精准化、个体化、成本低廉、简单易行。我们的目标是使癌症由绝症变为慢性病,最终能够被治愈。 Company introduction BenHealth Biopharmaceutical (Shenzhen) Co. Ltd is a company specialized in biopharmaceutics and cell therapy tools and technology innovations. Based on the past research on protein engineering, we have i***ented numerous lucrative tools for cell immunotherapy technology and engineering, including but not limited to the development of innovative bispecific antibody drugs, cell cultivating protocols, cell phenotype controls, magnetic-particle-based cell division methods and cell detections. Besides, focusing on different research fields such as AMT/AMNK cell targeting embellishment, CTL-targeted DC technology, TIL research and so on, we have built a series of forefront research platforms. BenHealth will continue to be creative and try to improve the quality of our products and technology, thus the immune therapy will be specialized and personalized, which will also be moneysaving and foolproof. Our aim is to change cancer from a lethal disease to a curative one.